CD274 and neoplasm: Currently, the mechanisms of immunotherapy resistance include a lack of neoantigens or abnormal antigen presentation, low tumor load, low PD-L1 expression, T-cell infiltration disorder or T-cell exhaustion, presence of immunosuppressive cells or factors, and abnormal signaling pathways (15).